A Comparison of Pneumococcal Nasopharyngeal Carriage in Very Young Fijian Infants Born by Vaginal or Cesarean Delivery.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 10 2019
Historique:
entrez: 19 10 2019
pubmed: 19 10 2019
medline: 19 6 2020
Statut: epublish

Résumé

Pneumococcal nasopharyngeal carriage is a prerequisite for pneumococcal disease. The main transmission route is from toddlers, who commonly carry pneumococci. However, neonatal pneumococcal disease case reports suggest that vertical pneumococcal transmission may also occur. To describe and compare pneumococcal nasopharyngeal carriage and density by infant mode of delivery in young Fijian infants. Annual cross-sectional surveys were performed in Suva, Fiji, before the introduction of 10-valent pneumococcal conjugate vaccine (PCV10), from September 14 to December 20, 2012, and after PCV10 was introduced, from July 11 to November 19, 2013; July 15 to December 9, 2014; and August 13 to November 19, 2015. Caregivers of 2006 infants aged 5 to 8 weeks participated in the surveys. Statistical analysis was performed from May 24, 2018, to August 12, 2019. Caregivers provided data on infant mode of delivery and demographics via interviewer-led survey. Pneumococci in swab samples were detected and quantified by lytA quantitative polymerase chain reaction with molecular serotyping by microarray. Pneumococci were categorized as PCV10 or non-PCV10 serotypes. Of the 2006 infants (976 girls and 1030 boys; mean [SD] age, 6.1 [0.02] weeks]), 1742 (86.8%) were born vaginally and 264 were born by cesarean delivery. Infants delivered vaginally, compared with those born by cesarean delivery, had a higher prevalence of overall pneumococcal nasopharyngeal carriage (470 of 1722 [27.3%; 95% CI, 25.2%-29.4%] vs 47 of 260 [18.1%; 95% CI, 13.6%-23.3%]; P = .002), PCV10 carriage (113 of 1698 [6.7%; 95% CI, 5.5%-7.9%] vs 8 of 256 [3.1%; 95% CI, 1.4%-6.1%]; P = .03), and non-PCV10 carriage (355 of 1698 [20.9%; 95% CI, 19.0%-22.9%] vs 38 of 256 [14.8%; 95% CI, 10.7%-19.8%]; P = .02), and had higher median densities of overall pneumococci (4.9 log10 genome equivalents [GE]/mL [interquartile range, 4.8-5.0 log10 GE/mL] vs 4.5 log10 GE/mL [interquartile range, 4.1-4.6 log10 GE/mL]; P = .01) and non-PCV10 pneumococci (4.9 log10 GE/mL [interquartile range, 4.7-5.0 log10 GE/mL] vs 4.4 log10 GE/mL [interquartile range, 4.0-4.7 log10 GE/mL]; P = .01). Vaginal delivery was associated with overall (adjusted odds ratio, 1.57 [95% CI, 1.10-2.23]; P = .01) and non-PCV10 (adjusted odds ratio, 1.49 [95% CI, 1.01-2.20]; P = .04]) pneumococcal nasopharyngeal carriage. Vaginal delivery was not associated with PCV10 carriage (adjusted odds ratio, 1.67 [95% CI, 0.80-3.51]; P = .17). After adjustment, vaginal delivery was not associated with density. Pneumococcal nasopharyngeal carriage prevalence and density were higher in infants delivered vaginally compared with those delivered by cesarean birth. After adjustment, vaginal delivery was associated with pneumococcal carriage. Differences in carriage by mode of delivery may be due to differential exposure to the vaginal microbiota during delivery and the effect of intrapartum antibiotics during cesarean delivery on the infant microbiome. Our findings also raise the hypothesis that vertical transmission may contribute to pneumococcal acquisition.

Identifiants

pubmed: 31626319
pii: 2753251
doi: 10.1001/jamanetworkopen.2019.13650
pmc: PMC6813584
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1913650

Références

Int J Clin Pharmacol Ther. 2006 Feb;44(2):57-63
pubmed: 16502764
Pathol Biol (Paris). 1987 Feb;35(2):177-80
pubmed: 3550628
J Clin Microbiol. 2007 Aug;45(8):2460-6
pubmed: 17537936
Pediatr Infect Dis J. 2013 Nov;32(11):1299-300
pubmed: 24141804
J Clin Microbiol. 2003 May;41(5):2258-60
pubmed: 12734296
Am J Obstet Gynecol. 1980 Jan 15;136(2):257
pubmed: 7352510
Clin Microbiol Infect. 2018 Apr;24(4):428.e1-428.e7
pubmed: 28736074
Pediatrics. 2003 Nov;112(5):1095-102
pubmed: 14595052
CMAJ. 1985 Nov 15;133(10):1019-20
pubmed: 4063901
Arch Dis Child. 1993 Sep;69(3 Spec No):317-8
pubmed: 8215574
Arch Gynecol Obstet. 2010 Nov;282(5):591-2
pubmed: 20428879
Vaccine. 2013 Dec 17;32(1):165-79
pubmed: 24331112
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11971-5
pubmed: 20566857
Infect Immun. 2003 Nov;71(11):6192-8
pubmed: 14573636
J Glob Health. 2011 Dec;1(2):154-70
pubmed: 23198116
Front Pediatr. 2016 Feb 23;4:10
pubmed: 26942168
Eur J Pediatr. 1995 Jul;154(7):563-6
pubmed: 7556324
J Perinat Med. 1990;18(2):125-9
pubmed: 2366133
Am J Epidemiol. 2019 Jan 1;188(1):160-168
pubmed: 30462150
Lancet Glob Health. 2018 Dec;6(12):e1375-e1385
pubmed: 30420033
Pediatr Infect Dis J. 1999 Oct;18(10 Suppl):S17-22
pubmed: 10530569
EBioMedicine. 2016 Jul;9:336-345
pubmed: 27333043
Postgrad Med J. 2004 Apr;80(942):196-200
pubmed: 15082839
Clin Pediatr (Phila). 2004 Jul-Aug;43(6):579-81
pubmed: 15248014
Pediatr Infect Dis J. 2016 Feb;35(2):172-9
pubmed: 26517330
Epidemiol Infect. 2017 Oct;145(13):2750-2758
pubmed: 28847317
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
JAMA. 1972 Mar 27;219(13):1763-4
pubmed: 4553451
J Infect. 1990 Jan;20(1):59-63
pubmed: 2299184
PLoS Med. 2015 Jun 09;12(6):e1001839
pubmed: 26057994
Clin Microbiol Infect. 2016 Jun;22(6):565.e1-9
pubmed: 27026482
Expert Rev Vaccines. 2012 Jul;11(7):841-55
pubmed: 22913260
Am J Perinatol. 2004 Nov;21(8):491-5
pubmed: 15580546
Am J Obstet Gynecol. 1989 Nov;161(5):1424-5
pubmed: 2589470
Vaccine Rep. 2016 Dec;6:36-43
pubmed: 28580433
Clin Infect Dis. 2014 Nov 15;59(10):e150-7
pubmed: 24997051
Pediatrics. 1977 Sep;60(3):352-5
pubmed: 19725
Ann Trop Paediatr. 2006 Sep;26(3):187-97
pubmed: 16925955
PLoS Med. 2015 Nov 17;12(11):e1001903; discussion e1001903
pubmed: 26575033
J Pediatr. 1975 Apr;86(4):593-5
pubmed: 236367
Microbiology. 2012 Jun;158(Pt 6):1560-9
pubmed: 22403189
Aust N Z J Obstet Gynaecol. 2017 Jun;57(3):280-285
pubmed: 27530965
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S200-S219
pubmed: 29117332
Pediatr Infect Dis J. 2011 Jan;30(1):11-8
pubmed: 20686433

Auteurs

Eleanor Frances Georgina Neal (EFG)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Centre for International Child Health, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Cattram Nguyen (C)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Felista Tupou Ratu (FT)

Ministry of Health and Medical Services, Suva, Fiji.

Silivia Matanitobua (S)

Ministry of Health and Medical Services, Suva, Fiji.

Eileen Margaret Dunne (EM)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Rita Reyburn (R)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.

Mike Kama (M)

Ministry of Health and Medical Services, Suva, Fiji.

Rachel Devi (R)

Ministry of Health and Medical Services, Suva, Fiji.

Kylie M Jenkins (KM)

Fiji Health Sector Support Program, Suva, Fiji.

Lisi Tikoduadua (L)

Ministry of Health and Medical Services, Suva, Fiji.

Joseph Kado (J)

College of Medicine Nursing and Health Sciences, Fiji National University, Suva, Fiji.
Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.

Eric Rafai (E)

Ministry of Health and Medical Services, Suva, Fiji.

Catherine Satzke (C)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia.

Edward Kim Mulholland (EK)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Fiona Mary Russell (FM)

Infection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
Centre for International Child Health, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH